ENIGMA+: a national, decentralized, remote consent study for clinical data and biospecimen collection in patients with ALK-positive advanced NSCLC
- DOI
- 10.1093/oncolo/oyaf217
- Published
- 2025-07-17
- Container
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/oncolo/oyaf217,
title = {ENIGMA+: a national, decentralized, remote consent study for clinical data and biospecimen collection in patients with ALK-positive advanced NSCLC},
author = {Joyce Liang and Sarah Waliany and Andrew Do and Jennifer L Peterson and Paige Roberts and Elizabeth A Kennedy and Emily S Venanzi and Justin F Gainor and Jessica J Lin},
year = {2025},
journal = {The Oncologist},
doi = {10.1093/oncolo/oyaf217},
url = {https://doi.org/10.1093/oncolo/oyaf217}
}RIS
TY - JOUR TI - ENIGMA+: a national, decentralized, remote consent study for clinical data and biospecimen collection in patients with ALK-positive advanced NSCLC AU - Joyce Liang AU - Sarah Waliany AU - Andrew Do AU - Jennifer L Peterson AU - Paige Roberts AU - Elizabeth A Kennedy AU - Emily S Venanzi AU - Justin F Gainor AU - Jessica J Lin PY - 2025 JO - The Oncologist DO - 10.1093/oncolo/oyaf217 UR - https://doi.org/10.1093/oncolo/oyaf217 ER -
APA
Liang, J., Waliany, S., Do, A., Peterson, J. L., Roberts, P., Kennedy, E. A., Venanzi, E. S., Gainor, J. F., & Lin, J. J. (2025). ENIGMA+: a national, decentralized, remote consent study for clinical data and biospecimen collection in patients with ALK-positive advanced NSCLC. The Oncologist. https://doi.org/10.1093/oncolo/oyaf217
Source records
- crossref · retrieved 2026-09-26T11:41:59.667Z